00300-7/asset/fc51add5-22b1-4645-9507-e89d0738c67a/main.assets/gr1_lrg.jpg)
foxo4-dri senolytic human trial 2024 The costs and benefits of senotherapeutics for health Peptide inhibitors targeting FOXO4-p53 interactions
Description
KhoshbinKKhannaLMaselliDAtiehJBreen-LylesMArndtKet al
doi: 10.1016/j.cytogfr.2024.08.004 [DOI] [PubMed] [Google Scholar] 60.Islam MT, Tuday E, Allen S, et al
S.SchneiderJ
Again, Epitalon was found to interact with a specific DNA sequencethis time, ATTTC
Patients who have struggled with appetite control, slow metabolism, or insulin resistance often respond well to peptide-based interventions
